VTE Incidence After Curative Colon Cancer Surgery in an ERAS Program

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2141 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-01-01

Study Completion Date

2018-03-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Based on data on a cohort of 2,141 patients undergoing elective colonic cancer resection in an ERAS program, the incidence of postoperative thromboembolic events is estimated in patients no receiving prolonged thromboembolic prophylaxis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Risk Factors of Venous Thromboembolism After Colorectal Cancer Surgery

NCT06302179

Colorectal Cancer Venous Thromboembolism

COMPLETED

Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal Cancer

NCT00660205

Thrombosis Deep Venous Thrombosis Pulmonary Embolism +4 more

COMPLETED

Postoperative VEGF and Recurrence After Colon Cancer Surgery

NCT04851054

Angiogenesis Colon Cancer Surgery +2 more

UNKNOWN

Changes in Coagulation in Colorectal Cancer Patients Undergoing Surgical Treatment

NCT04744688

Peritoneal Metastases Peritoneal Carcinomatosis Colorectal Neoplasms Malignant +11 more

COMPLETED

A Study of Initiation Timing of VTE Prevention After Colorectal Cancer Surgery

NCT06259149

Colorectal Cancer

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Copenhagen cOmplete Mesocolic Excision Study (COMES) database contains comprehensive data on preoperative, intraoperative, postoperative and tumor related variable on patients undergoing elective colonic cancer resection at four public university clinics providing all colorectal cancer treatment for the 1.8 million residents of the Capital Region of Denmark during the period 2014-2017.

None of these hospitals had implemented prolonged thromboembolic prophylaxis after discharge.

The medical records were reviewed with focusing on VTE prophylaxis, ongoing preoperative and postoperative anticoagulant treatment, the length of hospital stay (LOS), and readmission to ensure high data validity.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Deep Vein Thrombosis, Pulmonary Embolus Colon Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Colon resection

Colon cancer resection

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* elective macroradical resection for UICC Stage I-III colonic adenocarcinoma

Exclusion Criteria

* concomitant rectum resection
* soly appendix carcinoma
* diagnosed with pulmonary embolism or deep venous thrombosis before primary discharge
* dying before discharge from the hospital or discharged at postoperative day 28 or later
* treatment with vitamin K antagonists, heparin or new oral anticoagulants before or after surgery
* VTE less than 3 months before the colon resection

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No